Real-world implementation of guidelines for heart failure management: A systematic review and meta-analysis
Tài liệu tham khảo
Yoo, 2014, Survey of guideline adherence for treatment of systolic heart failure in Real World (SUGAR): a multi-center, retrospective, observational study, PLoS One, 9, 1, 10.1371/journal.pone.0086596
Chang, 2017, Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: results from TSOC-HFrEF registry, J Chinese Med Assoc [Internet], 10.1016/j.jcma.2017.04.011
McDonagh, 2021, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 42, 3599, 10.1093/eurheartj/ehab368
Yancy, 2017, ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Ame, Circulation, 136, e137, 10.1161/CIR.0000000000000509
Ponikowski, 2016, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution, Eur J Heart Fail, 18, 891, 10.1002/ejhf.592
Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, 10.1371/journal.pmed.1000097
Ankit R. WebPlotDigitizer [Internet]. Available from: https://automeris.io/WebPlotDigitizer.
Institute NHL and B. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [Internet]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
Altman, 2003, Interaction revisited: the difference between two estimates, BMJ, 326, 219, 10.1136/bmj.326.7382.219
Komajda, 2019, Physicians’ guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry, Eur J Heart Fail, 21, 921, 10.1002/ejhf.1459
von Scheidt, 2014, Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based treatment in Heart Failure (EVITA-HF) registry, Clin Res Cardiol, 103, 1006, 10.1007/s00392-014-0743-x
Thorvaldsen, 2016, Use of evidence-based therapy and survival in heart failure in Sweden 2003 – 2012, Eur J Heart Fail, 18, 503, 10.1002/ejhf.496
Eschalier, 2015, Impact of clinical characteristics and management on the prognosis of unselected heart failure patients, Cardiovasc Drugs Ther, 29, 89, 10.1007/s10557-015-6572-y
Chioncel, 2017, Epidemiology and one-year outcomes in patients with chronic heart failure and preserved , mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry, Eur J Heart Fail, 19, 1574, 10.1002/ejhf.813
Macdonald, 2019, Regional variation of mortality in heart failure with reduced and preserved ejection fraction across Asia: outcomes in the ASIAN-HF Registry, J Am Heart Assoc, 1–15
Tsigkas, 2021, Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions, Heart Fail Rev [Internet]
Tsigkas, 2021, Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis, J Geriatr Cardiol, 18, 352
Maggioni, 2010, EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot), Eur J Heart Fail, 12, 1076, 10.1093/eurjhf/hfq154
Rutten, 2003, Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice, Eur J Heart Fail, 5, 337, 10.1016/S1388-9842(03)00050-3
Ko, 2002, Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction, JAMA, 288, 351, 10.1001/jama.288.3.351
Manolis, 2019, Eplerenone versus spironolactone in resistant hypertension: an efficacy and/or cost or just a men's issue?, Curr Hypertens Rep, 21, 22, 10.1007/s11906-019-0924-0
Thomsen, 2018, Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study, Diabet Med, 35, 1051, 10.1111/dme.13687
Sarafidis, 2018, Mineralocorticoid receptor antagonists for nephroprotection: current evidence and future perspectives, Curr Pharmaceut Des, 24, 5528, 10.2174/1381612825666190306162658
Harris, 1995, Excess mortality of mental disorder, Br J Psychiatry, 173, 11
Brown, 2018, Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: a unique vascular transcriptomic signature, Pharmacol Res, 134, 100, 10.1016/j.phrs.2018.06.002
Liu, 2018, Spironolactone protects against diabetic cardiomyopathy in streptozotocin-induced diabetic rats, J Diabetes Res, 2018, 9232065
Komajda, 2009, Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II, Eur Heart J, 30, 478, 10.1093/eurheartj/ehn539
Fonarow, 2011, Potential impact of optimal implementation of evidence-based heart failure therapies on mortality, Am Heart J, 161, 1024, 10.1016/j.ahj.2011.01.027
Tavazzi, 2013, Multicenter prospective observational study on acute and chronic heart failure one-year follow-up results of IN-HF (Italian Network on Heart Failure) Outcome Registry, Circ Hear Fail, 473–82
Poelzl, 2014, Dose matters ! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure ☆ on behalf of the Austrian Working Group on Heart Failure, Int J Cardiol [Internet], 175, 83, 10.1016/j.ijcard.2014.04.255
Zannad, 2020, SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials, Lancet (London, England), 396, 819, 10.1016/S0140-6736(20)31824-9
Wang, 2016, TSOC-HFrEF Registry: a registry of hospitalized patients with decompensated systolic heart failure: description of population and management, Acta Cardiol Sin, 32, 400
Maggioni, 2013, EUR observational research programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot), Eur J Heart Fail, 15, 808, 10.1093/eurjhf/hft050